Ben-Noon Dagi Shahar, the Chief Executive Officer of QTREX Quantum Ltd., made a significant share purchase on October 9, 2026. Dagi acquired 18,181 ordinary shares at a price of $1.67 each. This transaction increases his total ownership to 3,664,314 shares, demonstrating a strong commitment to the company’s future.
The acquisition comes at a time when QTREX Quantum is navigating the surgical and medical instruments industry. Executive share purchases can often signal confidence in a company’s performance and future prospects, which may influence investor sentiment and market dynamics.
Background
QTREX Quantum Ltd. operates within the surgical and medical instruments and apparatus sector, classified under the SIC code 3841. The company is based in Ra'anana, L3, and has undergone a name change from Inspira Technologies OXY B.H.N. Ltd on December 21, 2020. Their recent filings indicate ongoing activity, with multiple Form 4 submissions in the past month.
What the Filing Says
According to the SEC filing, Dagi’s purchase of shares was made in the open market and is part of a management share purchase plan announced by the company on June 22, 2026. The filing states, "The shares were purchased in the open market," highlighting a proactive approach by the CEO to align his interests with those of shareholders.
Impact
This acquisition may impact various stakeholders, including current investors, potential investors, and the broader surgical and medical instruments industry. Executives buying shares can create a ripple effect, encouraging other leaders within the sector to follow suit, potentially leading to increased market confidence.
What's Next
The filing does not say what happens next.